Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 12:58 pm Sale |
2025-02-28 | 13G | Protara Therapeutics, Inc. TARA |
JANUS HENDERSON GROUP PLC JHG |
3,788,176 10.300% |
-1,660,511 (-30.48%) |
Filing History |
| 2025-02-14 6:40 pm Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
RA Capital Management, L.P. | 3,431,713 9.900% |
1,358,638 (+65.54%) |
Filing History |
| 2025-02-14 6:24 pm Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Citadel Advisors LLC | 1,627,734 4.700% |
414,602 (+34.18%) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Woodline Partners LP | 1,331,258 3.900% |
-245,309 (-15.56%) |
Filing History |
| 2025-02-14 11:23 am Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
JANUS HENDERSON GROUP PLC JHG |
5,448,687 6.600% |
5,448,687 (New Position) |
Filing History |
| 2025-02-14 06:31 am Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 1,825,000 5.320% |
143,846 (+8.56%) |
Filing History |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Adage Capital Management L.P. | 2,250,000 6.560% |
2,250,000 (New Position) |
Filing History |
| 2024-12-17 4:02 pm Purchase |
2024-12-10 | 13G | Protara Therapeutics, Inc. TARA |
Velan Capital Investment Management LP | 2,059,000 5.900% |
2,059,000 (New Position) |
Filing History |
| 2024-11-18 06:01 am Purchase |
2024-09-30 | 13G | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 1,681,154 8.150% |
1,681,154 (New Position) |
Filing History |
| 2024-11-14 1:00 pm Purchase |
2024-09-30 | 13G | Protara Therapeutics, Inc. TARA |
Woodline Partners LP | 1,576,567 7.400% |
1,576,567 (New Position) |
Filing History |
| 2024-11-14 12:19 pm Unchanged |
2024-09-30 | 13G | Protara Therapeutics, Inc. TARA |
CVI Investments, Inc. | 600,380 2.800% |
0 (Unchanged) |
Filing History |
| 2024-04-25 8:43 pm Purchase |
2024-04-10 | 13G | Protara Therapeutics, Inc. TARA |
RA Capital Management, L.P. | 2,073,075 9.990% |
2,073,075 (New Position) |
Filing History |
| 2024-04-22 4:05 pm Purchase |
2024-04-10 | 13G | Protara Therapeutics, Inc. TARA |
Citadel Advisors LLC | 1,213,132 5.700% |
1,213,132 (New Position) |
Filing History |
| 2024-04-09 10:43 am Purchase |
2024-04-05 | 13G | Protara Therapeutics, Inc. TARA |
CVI Investments, Inc. | 600,380 5.300% |
600,380 (New Position) |
Filing History |
| 2024-02-14 7:11 pm Sale |
2023-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 0 0.000% |
-671,741 (Position Closed) |
Filing History |
| 2023-02-14 4:52 pm Unchanged |
2022-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 671,741 6.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:59 pm Sale |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
PERCEPTIVE ADVISORS LLC | 421,641 3.800% |
-186,903 (-30.71%) |
Filing History |
| 2022-02-14 6:27 pm Sale |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Rock Springs Capital Management LP | 0 0.000% |
-643,200 (Position Closed) |
Filing History |
| 2022-02-14 4:39 pm Sale |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Ikarian Capital LLC | 279,256 2.500% |
-370,286 (-57.01%) |
Filing History |
| 2022-02-11 4:40 pm Purchase |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 671,741 6.000% |
671,741 (New Position) |
Filing History |